Illinois professor granted $4.5M for breast cancer research

Part of Dr. Nelsons upcoming research study initiative includes a job that tries to prevent the synthesis of 27-HC and develop drugs that target essential regulators of cholesterol metabolism..

More posts on oncology: Flash radiation therapy can help treat cancer without damaging impacts, study findsWomen with inflammatory breast cancer now living longer, but racial disparities stay, study says4 recent cancer care partnerships.

” One of the big things is determining why and how breast cancer cells can lay dormant for several years and after that suddenly reemerge,” said Dr. Nelson. “The other element of that is were trying to remove the mortality associated with metastatic breast cancer, which accounts for more than 90 percent of all breast cancer-associated deaths.”.

Dr. Nelson, integrative and molecular physiology professor at University of Illinois Urbana-Champaign, will study numerous key gaps associated with breast cancer.

The U.S. Department of Defense Breast Cancer Research Program granted Erik Nelson, PhD, the $4.5 million Era of Hope Scholar Award Oct. 30 to lead a research team that will study metastatic breast cancer treatment and avoidance..

Dr. Nelsons research team previously recognized cholesterol as an essential part of cancer and immune cell guideline, which helps to discuss why patients with high cholesterol levels experience recurrence quicker. Supporting research study found that 27-hydroxycholesterol, a metabolite of cholesterol, can trigger the estrogen receptor that drives development in breast cancer patients, the statement said..

Erica Carbajal –
Monday, November 2nd, 2020
Print|Email.

© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this material? View our policies by clicking here.